Newsroom
April 15, 2022
The UT Health San Antonio School of Dentistry is partnering with The Oral Cancer Foundation to host The San Antonio Oral Cancer Walk 2022 on Saturday, April 23, celebrating oral cancer survivors and honoring those lost to the disease.
April 11, 2022
Registration underway for event at UT Health San Antonio Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – The UT Health San Antonio School of Dentistry is partnering with The Oral Cancer Foundation to host The San Antonio Oral Cancer Walk 2022 on Saturday, April 23, celebrating oral cancer survivors and honoring those lost to the […]
April 1, 2022
Structural racism, rather than disease, leads to inequities, authors write Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of the COVID-19 and Cancer Consortium (https://ccc19.org/), which includes more than 125 cancer centers and other organizations, studied […]
March 29, 2022
Findings for more than 200 countries to be available to stakeholders globally Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – Persons aged 70 years or more worldwide were found to live more than two years longer in 2019 than in 1990, with increases in almost all of more than 200 countries, according to a landmark […]
March 28, 2022
Structural racism, rather than disease, leads to inequities, authors write Contacts: Will Sansom, (210) 567-2579, sansom@uthscsa.edu Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO (March 28, 2022) — Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of […]
March 10, 2022
An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]
